Noxxon Pharma NV

12/29/2021 | Press release | Distributed by Public on 12/29/2021 10:51

NOXXON secures Euro 17 million expansion of equity-linked facility with Atlas to advance NOX-A12 in glioblastoma and pancreatic cancer programs